This trial studies an internet-based intervention for skin self-examination (SSE) in participants with increased risk for melanoma. Early detection of suspicious growths on the skin can be done by performing regular SSE checks. Using an internet-based intervention, such as mySmartCheck, may help to promote regular, thorough checks on the skin in participants with increased risk for melanoma.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT03725449.
PRIMARY OBJECTIVE:
I. To evaluate the impact of mySmartCheck on SSE behaviors among individuals at increased risk for developing melanoma.
SECONDARY OBJECTIVES:
I. To evaluate the impact of mySmartCheck versus usual care on patients’ barriers and benefits to conducting SSE, SSE self-efficacy (confidence), level of worry about developing melanoma, and number of health care consultations (visits, telephone calls, and emails).
II. To identify barriers and facilitators to using mySmartCheck.
OUTLINE:
PHASE I: Participants attend a telephone interview and participate in 2-5 user testing sessions of mySmartCheck program over 60 minutes each for acceptability, satisfaction, comprehension, and usability.
PHASE II: Participants are randomized to 1 of 2 groups.
GROUP I: Participants attend a telephone interview over 15-20 minutes, receive access to mySmartCheck program, and continue to receive standard of care.
GROUP II: Participants receive standard of care.
After completion of study, patients are followed up for 13 weeks.
Trial PhaseNo phase specified
Trial Typeprevention
Lead OrganizationRutgers Cancer Institute of New Jersey
Principal InvestigatorSharon Manne
